Impact of socioeconomic disparities on cause-specific survival of retinoblastoma

Cheung,Rex

doi:10.3892/mco.2013.83

Impact of socioeconomic disparities on cause-specific survival of retinoblastoma

Authors:
- Rex Cheung
View Affiliations

Affiliations: Bryn Mawr, PA 19010, USA
Published online on: March 1, 2013 https://doi.org/10.3892/mco.2013.83
Pages: 535-540

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Retinoblastoma (RB) is a rare disease of infancy and early childhood. This study investigated the effects of socioeconomic factors on the cause-specific survival of RB. Data from patients diagnosed with RB between 1973 and 2009 were obtained from the Surveillance, Epidemiology and End Results (SEER) database. The study included 1,456 patients with a the mean follow-up time (SD) of 128.75 (113.74) months and a mean age (SD) of 1.4 (2.6) years. This study analyzed socioeconomic, staging and treatment factors available in the SEER database for RB. Kaplan-Meier analysis was used to analyze time‑to‑failure data. The two‑sample Kolmogorov‑Smirnov test was used for univariate analysis and the Cox proportional hazards model was used for multivariate analysis. The area under the receiver operating characteristic (ROC) curve was computed for predictors. SEER stage was the most significant predictive pretreatment factor. The identified socioeconomic barriers included ethnicity and rural-urban residence status that led to a 3% decrease in RB cause-specific survival. Thus, eliminating barriers to treatment is crucial for reducing the outcome disparities.

View Figures

View References

1.	Broaddus E, Topham A and Singh AD: Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 93:21–23. 2009.
2.	Abramson DH, Marr BP, Brodie SE, et al: Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS One. 7:e341202012.PubMed/NCBI
3.	Broaddus E, Topham A and Singh AD: Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 93:24–27. 2009.
4.	Sastre X, Chantada GL, Doz F, et al: Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 133:1199–1202. 2009.
5.	Schvartzman E, Chantada G, Fandino A, et al: Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol. 14:1532–1536. 1996.PubMed/NCBI
6.	Pui CH, Pei D, Pappo AS, et al: Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children’s Research Hospital, 1992 through 2007. J Clin Oncol. 30:2005–2012. 2012.PubMed/NCBI
7.	Liu L, Krailo M, Reaman GH and Bernstein L: Childhood cancer patients’ access to cooperative group cancer programs: a population-based study. Cancer. 97:1339–1345. 2003.
8.	Kleinerman RA, Tucker MA, Abramson DH, et al: Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst. 99:24–31. 2007. View Article : Google Scholar : PubMed/NCBI
9.	Lanier AP, Holck P, Ehrsam Day G and Key C: Childhood cancer among Alaska natives. Pediatrics. 112:e3962003. View Article : Google Scholar : PubMed/NCBI
10.	Gatta G, Capocaccia R, Coleman MP, Ries LA and Berrino F: Childhood cancer survival in Europe and the United States. Cancer. 95:1767–1772. 2002. View Article : Google Scholar : PubMed/NCBI
11.	Breslow NE and Langholz B: Childhood cancer incidence: geographical and temporal variations. Int J Cancer. 32:703–716. 1983. View Article : Google Scholar : PubMed/NCBI
12.	Cheung R: Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: a US SEER data analysis. Asian Pac J Cancer Prev. 13:4587–4591. 2012. View Article : Google Scholar
13.	Cheung R, Altschuler MD, D’Amico AV, et al: ROC optimization may improve risk stratification of prostate cancer patients. Urology. 57:286–290. 2001. View Article : Google Scholar : PubMed/NCBI
14.	Cheung R, Altschuler MD, D’Amico AV, et al: Using the receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure. Urology. 58:400–405. 2001. View Article : Google Scholar : PubMed/NCBI
15.	Vasudevan V, Cheung MC, Yang R, et al: Pediatric solid tumors and second malignancies: characteristics and survival outcomes. J Surg Res. 160:184–189. 2010. View Article : Google Scholar : PubMed/NCBI
16.	Ludwig J, Sanbonmatsu L, Gennetian L, et al: Neighborhoods, obesity, and diabetes - a randomized social experiment. N Engl J Med. 365:1509–1519. 2011. View Article : Google Scholar : PubMed/NCBI
17.	Ludwig J, Duncan GJ, Gennetian LA, et al: Neighborhood effects on the long-term well-being of low-income adults. Science. 337:1505–1510. 2012. View Article : Google Scholar : PubMed/NCBI
18.	Chang JW, Yu YS, Kim JY, et al: The clinical outcomes of proton beam radiation therapy for retinoblastomas that were resistant to chemotherapy and focal treatment. Korean J Ophthalmol. 25:387–393. 2011. View Article : Google Scholar : PubMed/NCBI
19.	Munier FL, Verwey J, Pica A, et al: New developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques. Clin Experiment Ophthalmol. 36:78–89. 2008. View Article : Google Scholar : PubMed/NCBI
20.	DeLaney TF: Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center. Technol Cancer Res Treat. 6(Suppl 4): 61–66. 2007. View Article : Google Scholar : PubMed/NCBI
21.	Hanley JA and McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:29–36. 1982. View Article : Google Scholar : PubMed/NCBI